Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DOMUS: A Randomized Controlled Clinical Trial of Accelerated Transition From Oncological Treatment to Continuing Palliative Care at Home
Brief Summary: Danish studies have shown that the majority of palliative cancer patients wish to be cared for and spend the rest of their lives at home. Nevertheless \> 50% of palliative cancer patients die in acute hospitals and these figures are found in countries with a highly developed palliative care service as well. Some studies have suggested that, among other causes, delays in the discharge process represent a significant obstacle for achieving care and treatment, and ultimately death at home. Therefore, this randomized controlled trial (RCT) aims at investigating an accelerated transition program from oncological treatment to continuous specialized palliative care at home for patients with incurable cancer. The primary objective of the study is to investigate whether an accelerated transition from oncology care to palliative home care significantly increases home care and death. The secondary objectives are to investigate whether the intervention improves symptom control and quality of life, increases survival, affects health care expenses, improves caregiver quality of life and burden, dyadic coping and grief outcomes. The study will take place in the departments of oncology at Rigshospitalet, where palliative cancer patients will enter the intervention or usual care arms. The intervention is an accelerated transition program, which consists of planning palliative home care and if needed optimization of facilities at home, and a transfer to home care within 5 days of informed consent. On day 1 at home the patient, informal caregiver, nurse, representatives of the specialized palliative care team and if possible the general practitioner and project psychologist meet to organize home care. A dyadic psychological intervention is offered to patients and their informal caregiver during specialized palliative care at home and to bereaved caregivers. The control group will be treated according to the usual principles, but if inadequate palliative care is observed in this group, the study group is obliged to involve responsible professionals. Both groups will be followed by assessments of the patient and the caregiver for up to 6 months and the caregivers 19 month after the patient's death.


Options:
A: Arm Label: Home-based Palliative Care; Type: EXPERIMENTAL; Interventions: Other: Home-based palliative care | Arm Label: Enhanced Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced usual care | Intervention Type: OTHER; Name: Home-based palliative care; Assigned to Arm(s): Home-based Palliative Care | Intervention Type: OTHER; Name: Enhanced usual care; Assigned to Arm(s): Enhanced Usual Care
B: Arm Label: Usual Care + Transitional Care Model; Type: EXPERIMENTAL; Interventions: Behavioral: Transitional Care Model, Behavioral: Usual care | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Transitional Care Model; Assigned to Arm(s): Usual Care + Transitional Care Model | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care, Usual Care + Transitional Care Model
C: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: OTHER; Interventions: Other: Transition program | Intervention Type: OTHER; Name: Transition program; Assigned to Arm(s): Intervention Group
D: Arm Label: Integrated care; Type: EXPERIMENTAL; Interventions: Other: Integrated care | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Integrated care; Assigned to Arm(s): Integrated care | Intervention Type: OTHER; Name: Integrated care; Assigned to Arm(s): Integrated care

Answer: C